Darktrace extends Enterprise Immune System to protect dynamic workforces
Darktrace, the world’s leading cyber AI company, has announced a range of new products and features that extend its Enterprise Immune System platform to endpoints, video and chat apps, SaaS applications, and identity and access management integrations to protect today’s remote and dynamic workforces.
Birketts advises Vanilla Electronics on PE investment from Literacy
Leading East of England law firm Birketts has advised the shareholders of Vanilla Electronics on a significant investment from Literacy Capital plc. The terms of the transaction were not disclosed.
Startup innovation boost
Two cutting-edge startups currently on the Accelerate Cambridge programme run by the Entrepreneurship Centre at Cambridge Judge Business School receive £100,000-plus Innovate UK funding boost.
Organisational culture matters
There are some key techniques to help an organisation’s culture survive despite staff working remotely, says Professor Jennifer Howard-Grenville of Cambridge Judge Business School.
Secrets of naked mole-rat cancer resistance unearthed
Naked mole-rats can live for an incredibly long time and have an exceptional resistance to cancer thanks to unique conditions in their bodies that stop cancer cells multiplying, according to new research.
Women who experience high blood pressure during pregnancy are more likely to develop heart disease
Women who experience high blood pressure during pregnancy are more likely to develop heart disease and heart failure in later life, according to an international team of researchers.
Affordable homes success could pave way for more schemes in other South Cambs villages
An initiative to provide local affordable homes for local people in South Cambridgeshire is celebrating its first major milestone – and it is hoped it will be the forerunner to other similar schemes elsewhere in the district.
Governance for SME and start up directors for HSE compliance
Inspiration-all Ltd offers a new and unique online managed service to support organisations to assess their current Health, Safety and Wellbeing maturity directly against HSE legislation and ISO standards.
EY appoints Adrian Bennett to support growth across the East of England
EY has welcomed partner Adrian Bennett to its East of England assurance team, to help support growth in the Cambridge office and across the wider region.
Who's Who Legal recognises outstanding practitioner
Taylor Wessing's Paul Callaghan has been named a Global Elite Thought Leader in Who's Who Legal Labour & Employment 2020 - Legal Marketplace Analysis.
Chris Turley and Clare Harman Clark write for PropertyEU on 'COVID-19' clauses in leases
As the world adjusts to the impact of coronavirus, the real estate sector is focusing on preventative measures that will protect their interests in the future, and from future pandemics.
Ross McNaughton joins Taylor Wessing as a new partner hire
Taylor Wessing is pleased to announce the appointment of Ross McNaughton as partner in its corporate technology team, based in Cambridge. Ross joins the firm on 1 July.
Coping with redundancy
Redundancy occurs when an employee is dismissed due to the closure or intended closure of a business or when there is a reduction in the workforce. COVID-19 has caused a huge increase in the numbers of redundancies companies are making across the UK.
Keeping employees motivated through tough times
From showing employee appreciation to nurturing skills, there are plenty of cost-effective ways to motivate your staff at a time like this. The HR Dept suggests a few to get you started...
EnfuseNet: Rewriting the economics of vehicle autonomy
Cambridge Consultants has developed EnfuseNet, a breakthrough Artificial Intelligence (AI) system for autonomous vehicles - a low-cost system that generates high-resolution depth data for vehicle perception technology.
Xaar celebrates 30 years as an industrial inkjet innovator
Xaar is celebrating its 30th birthday in style with champagne sent to every member of the team to toast the business and its role in pioneering the use of industrial inkjet technologies around the world.
Preliminary trial results find antiviral drug lopinavir/ritonavir does not reduce death in hospitalised patients with COVID-19
The ‘RECOVERY’ trial has released preliminary results showing lopinavir/ritonavir, an antiviral drug commonly used to treat HIV, had no significant mortality benefit in hospitalised COVID-19 patients.
Summer is here, time to escape to the big outdoors!
The fields of LodeStar, covering 200 acres of fine lawn just outside Cambridge, are opening from mid July to mid August for Covid-19 safe camping.
De-risking drug innovation: biotech vs big pharma
Most approved “priority” medicines are developed by biotech rather than large pharmaceutical firms, says a two-decade study at the University of Cambridge Judge Business School.
BioStrata further strengthens specialist life science marketing team with new hires
BioStrata, the life science marketing specialist, has appointed two new recruits further advancing the agency’s expert marketing team.
Playtime with dad may improve children’s self-control
Children whose fathers make time to play with them from a very young age may find it easier to control their behaviour and emotions as they grow up, research suggests.
Announcing the Cambridge Folk Festival at Home 2020
The Cambridge Folk Festival at Home 2020 will be a celebration of all things Cambridge that you can enjoy from your garden or living room.
Further £191m support package unveiled to help innovative businesses bounce back from COVID-19 impact
Innovate UK, part of UK Research and Innovation, has launched a new fund to help cutting-edge companies of all sizes recover, grow, and drive a re-building economy.
Swiss Life REIM (France) entrusts Taylor Wessing with Hamburg office building disposal for EUR 150m
Taylor Wessing has advised Swiss Life REIM (France) on the disposal of “Neuer Dovenhof” in Hamburg to Zurich. The net purchase price amounts to approximately EUR 150 million.
Cambridge spin-out PharmEnable raises £1.8m for drug discovery expansion
PharmEnable, a Cambridge-based drug discovery company using advanced medicinal chemistry and AI-enabled approaches to design the next generation of highly complex and specific drug candidate molecules, announces it has closed a £1.8 million seed financing to support its transition into a drug development company.